CLINICAL STUDY AGREEMENT (CRO-Janssen-Institution/Principal Investigator) SMLOUVA O PROVEDENÍ KLINICKÉHO HODNOCENÍ (CRO-Janssen-Zdravotnické zařízení/Hlavní zkoušející)Clinical Study Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020This Clinical Study Agreement (the “Agreement”) is by and between PAREXEL International (IRL) Limited (“CRO”), a Ireland corporation, with registered offices at 70 Sir John Rogerson's Quay, Dublin 2, Ireland and Janssen Research & Development, LLC (“Janssen”), a United States of America corporation, with registered offices at 1125 Trenton-Harbourton Road, Titusville, NJ 08560, United States, hereby represented by CRO and Slezská nemocnice Opava v Opavě, contributory organization (“Institution”) located at Olomoucká 470/86, Předměstí, 746 01 Opava, Czech Republic ,Iden. Number: 47813750 Tax Iden.number:CZ47813750 Entered in Companies Register: registered by kept by the l Court in Ostrava represented by : MUDr. Ladislav Václavec, MBA. And (“Principal Investigator”), affiliated with Institution, Slezská nemocnice v Opavě, příspěvková organizace, located at Olomoucká 470/86, Předměstí, 746 01 Opava, Czech Republic and is effective as of the date of execution by the last